Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Cardiovascular disease (CVD) is the leading cause of death worldwide, and prevention plays a critical role. Despite available treatment for tobacco addiction, blood pressure, and lipid lowering for reduction of atherosclerotic disease, significant gaps in treatment of total CVD remain. New preventive treatment options, including drugs for tobacco cessation, lipid- and blood pressure-lowering; non pharmacologic options such as left atrial appendage closure devices and strategies such as fixed-dose combination drugs and community-based prevention programs. CVD preventive research continues to evolve and provide clinicians and patients with novel pharmacologic and non pharmacologic therapies, including new preventive strategies.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi